Syncona Partners Visit

Syncona Partners Visit

Thursday 2nd April 2015; 10.30am - 12.45pm (followed by pre-booked 121 sessions)
Core Technology Facility, 46 Grafton Street, Manchester, M13 9NT

UMIP are hosting an event with Syncona Partners on the Thursday 2nd April (www.synconapartners.com - independent investment subsidiary of Wellcome Trust) and we would like to invite you to attend.

Iraj Ali, partner of Syncona Partners, is joining us to give a talk to an invited audience of academics, University business managers and UMIP about Syncona’s investment strategy and interests. This will then be followed by a number of 30 minute 121 sessions with individuals who might have ideas to discuss.

Areas of Interest

Syncona Partners are interested in Gene and Cell Therapy, including:

Engineered Cell Therapy

•T-cell focus •Chimeric antigen receptor approaches •Extreme efficacy in end-stage cancer patients •Autologous product delivery infrastructure

Patient Stratification

•Patient selection to deliver extreme efficacy •Clinical genomics •Molecular Imaging

Gene Therapy

•Lentiviral & AAV vector delivery •Severe monogenic disorders •Eye, liver, CNS opportunities •Pediatricinherited diseases

Targeted Medicine is a theme common to all Target Areas

•Extreme efficacy in targeted patient groups •Health-economic outcomes & reimbursement driven by patient targeting

They are actively exploring new Health Care Investment Themes (“HIT”)

Agenda

10.30 – Arrival
10.40 – Welcome and overview of UMIP
10.50 – Overview of Syncona covering:
i) Investment strategy
ii) Criteria for selecting technology for investment
iii) Examples of their portfolio companies
11.20 – Q&A
12.00 – Close & Lunch
12.45 – Pre-arranged 30 minute 121 sessions begin with academics/companies
15.15 – Close of 121 sessions

If you have any queries regarding the event please contact ellie.buckley@umip.com